SHILPAMED Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > shilpamed

Technical Analysis

Technical Strength: 5.2 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 51.9. According to RSI analysis, shilpamed is marginally strong. 6.0 SHILPAMED RSI Chart
MACD (?) MACD: 7.79 and Signal Line: 9.8. According to MACD analysis, a bearish crossover just happend and it's a negative signal. 0.0 SHILPAMED MACD Chart
Simple Moving Average (?) Price just got above it's 20-day simple moving average which is a positive signal. According to simple moving average analysis, shilpamed is facing resistance from it's 200-day simple moving average at 331.142 and support level is at 295. 7.0 SHILPAMED Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, shilpamed is facing resistance from it's 200-day exponential moving average at 327.3495 and support level is at 296. 7.0 SHILPAMED Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.514. 5.0 SHILPAMED Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above 61.8% and 50% level. Support is at 294.525 and 284.3711. Resistance level is 304.6789. 8.0 SHILPAMED Fibonacci Retracement Chart
Average True Range (?) ATR: 15.9 NA SHILPAMED Average True Range Chart
Average Directional Index (?) ADX is 28.6 which means SHILPAMED is in a trend. NA SHILPAMED Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
November 19, 2019
Open Price 297.5
High Price 300.0
Low Price 294.05
Close Price 296.25
Absolute Change 8.2
Percentage Change 2.85%
Weekly Change -9.73%
Monthly Change 11.1%
Yearly Change -25%
52-week high 435.05
52-week low 208.1
Corporate Actions
ExDate Purpose
September 12, 2019 AGM/DIV-RS 1 PER SH
September 06, 2018 ANNUAL GENERAL MEETING
March 01, 2018 INT DIV RE 0.70 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.758
Confidence in Beta7.7%
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 19 November 2019: Deliverable Quantity:6.02e+03 NA SHILPAMED Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 19 November 2019: Daily Volatility:0.6056 NA SHILPAMED Annualized Daily Volatility (Spot Price) Chart

Announcements

April 23, 2018 SUpdatesShilpa Medicare Limited has informed the Exchange regarding 'that the Company has received EU-GMP certification from Austrian Agency, AGES for its two API Manufacturing Plants located at Raichur, Karnataka and Formulation Facility located at Jadcherla, Telangana. Austrian Agency, AGES carried out audit of said API plants between January 16th and January 24th, 2018 and Formulation Facility between January 25th and January 31st, 2018.
April 09, 2018 PDisc. under Reg.30 of SEBI (SAST) Reg.2011Promoter of the Company has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
See all Announcements

Board Meetings

Date Meeting Date Purpose
October 31, 2019 November 09, 2019 Financial Results To consider and approve the financial results for the period ended September 30, 2019
August 06, 2019 August 13, 2019 Financial Results/Other business matters To consider and approve the financial results for the period ended Jun 30, 2019 and other business matters
See all Board Meetings

Get Clearnifty's Android App.

Get clearnifty on Google Play
Get clearnifty on Google Play